Amneal Pharmaceuticals, Inc.
- AMRX
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Generic/Specialty Pharmaceuticals
$19.36
Today +0.94%Quote Oct 19, 2026, 08:00 PM UTC
+3.47%over the last month
Max drawdown −7.8%From 1-month high −5.6%3 months +7.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
8,700
Market value
$6.18B
Quote Oct 19
Floor
$18.55
4.2% below price
Resistance
$19.51
0.8% above price
Price vs analyst targets
17 analysts
Lowest target
$20.00Highest target
$27.00
$20.00Highest target
$27.00
- Price $19.36
- Average target $23.20
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 20% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AMRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free